13.39
price up icon9.93%   1.21
after-market Dopo l'orario di chiusura: 13.47 0.08 +0.60%
loading
Precedente Chiudi:
$12.18
Aprire:
$13.74
Volume 24 ore:
19,473
Relative Volume:
0.27
Capitalizzazione di mercato:
$347.53M
Reddito:
$26.00M
Utile/perdita netta:
$-219.71M
Rapporto P/E:
-0.2689
EPS:
-49.8
Flusso di cassa netto:
$-51.37M
1 W Prestazione:
+0.90%
1M Prestazione:
+36.22%
6M Prestazione:
-31.05%
1 anno Prestazione:
-21.28%
Intervallo 1D:
Value
$13.39
$13.81
Intervallo di 1 settimana:
Value
$11.80
$13.81
Portata 52W:
Value
$8.46
$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Name
Nome
Cartesian Therapeutics Inc
Name
Telefono
301-348-8698
Name
Indirizzo
7495 NEW HORIZON WAY, FREDERICK
Name
Dipendente
66
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
RNAC's Discussions on Twitter

Confronta RNAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RNAC
Cartesian Therapeutics Inc
13.39 316.12M 26.00M -219.71M -51.37M -49.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-09 Iniziato Wedbush Outperform
2024-12-19 Iniziato BTIG Research Buy
2024-08-06 Iniziato TD Cowen Buy
2024-07-02 Downgrade Oppenheimer Outperform → Perform
2024-06-04 Iniziato Oppenheimer Outperform
2024-05-24 Iniziato Mizuho Buy
2024-04-23 Reiterato H.C. Wainwright Buy
2024-04-23 Iniziato Leerink Partners Outperform
2023-08-18 Downgrade SVB Securities Outperform → Market Perform
2022-06-14 Reiterato Needham Buy
2022-06-06 Iniziato SVB Leerink Outperform
2021-06-15 Iniziato BTIG Research Buy
2021-01-26 Aggiornamento Mizuho Neutral → Buy
2020-10-01 Downgrade Mizuho Buy → Neutral
2020-10-01 Downgrade William Blair Outperform → Mkt Perform
2020-06-12 Downgrade Stifel Buy → Hold
2020-04-28 Iniziato H.C. Wainwright Buy
2020-01-29 Iniziato Cantor Fitzgerald Overweight
2020-01-21 Iniziato William Blair Outperform
2018-06-27 Iniziato Janney Buy
2017-03-30 Reiterato UBS Buy
Mostra tutto

Cartesian Therapeutics Inc Borsa (RNAC) Ultime notizie

pulisher
Jul 23, 2025

Cartesian Therapeutics Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Cartesian Therapeutics Inc. a good long term investmentSkyrocketing investment returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Cartesian Therapeutics Inc. stock priceRapid growth trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Cartesian Therapeutics Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Cartesian Therapeutics Inc. stock price move sharplyFree Stock Market Swing Trading Strategies - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Multiple Myeloma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis CASI Pharmaceuticals, Carsgen Therapeutics, Cartesian Therapeutics - MenaFN

Jul 22, 2025
pulisher
Jul 15, 2025

Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Cartesian Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $40.00 Average Price Target from Analysts - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

What is Wedbush’s Estimate for RNAC Q2 Earnings? - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Wedbush Initiates Coverage on Cartesian Therapeutics (NASDAQ:RNAC) - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

CartesianAutoimmune Cell Therapy Excites, But Reality Bites (NASDAQ:RNAC) - Seeking Alpha

Jul 10, 2025
pulisher
Jul 09, 2025

Wedbush initiates coverage on Cartesian Therapeutics stock with Outperform rating - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

Cartesian stock up as Wedbush becomes bullish (RNAC:NASDAQ) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Cartesian Therapeutics' 15min chart sees KDJ Golden Cross, bullish Marubozu formation. - AInvest

Jul 09, 2025
pulisher
Jun 30, 2025

AbbVie Makes Big Autoimmune CAR-T Play With Capstan Acquisition - insights.citeline.com

Jun 30, 2025
pulisher
Jun 28, 2025

What caused RNAC's earnings to miss forecasts in Q4 2023? - AInvest

Jun 28, 2025
pulisher
Jun 26, 2025

Rhumbline Advisers Grows Stock Position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 26, 2025
pulisher
Jun 21, 2025

We're Not Very Worried About Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate - Yahoo Finance

Jun 21, 2025
pulisher
Jun 18, 2025

Myasthenia Gravis Market to Expand Significantly by 2034, States DelveInsight Report | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen Research & Development, LLC - The Globe and Mail

Jun 18, 2025
pulisher
Jun 18, 2025

IBM Introduces Industry-First Software to Unify Agentic Governance and Security - The Globe and Mail

Jun 18, 2025
pulisher
Jun 16, 2025

Cartesian Therapeutics holds annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

Cartesian Therapeutics holds annual stockholders meeting - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Cartesian Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Reduces Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Equities Analysts Offer Predictions for RNAC FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Buys 47,889 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewswire

Jun 04, 2025
pulisher
Jun 03, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants | RNAC Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cartesian Therapeutics (RNAC) Issues Inducement Stock Options to New Employees | RNAC Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cartesian Therapeutics Awards 26,350 Stock Options to Key New Hires in Autoimmune Disease Research - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

Jun 03, 2025

Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):